Sherry Y. Wu
Shenyang Medical College(CN)National Chung Cheng University(TW)Queensland University of Technology(AU)The University of Queensland(AU)State Grid Corporation of China (China)(CN)University of Toronto(CA)Chinese Academy of Sciences(CN)Liaoning University of Traditional Chinese Medicine(CN)Nanfang Hospital(CN)Academy of Mathematics and Systems Science(CN)State Nuclear Power Technology Company (China)(CN)University of Chinese Academy of Sciences(CN)Southern Medical University(CN)Hubei University(CN)
Publications by Year
Research Areas
MicroRNA in disease regulation, Epigenetics and DNA Methylation, RNA Interference and Gene Delivery, RNA modifications and cancer, Protein Degradation and Inhibitors
Most-Cited Works
- → Advances and Challenges of Liposome Assisted Drug Delivery(2015)2,466 cited
- → Tumour angiogenesis regulation by the miR-200 family(2013)413 cited
- → Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread(2014)320 cited
- → A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis(2013)309 cited
- → RNAi Therapies: Drugging the Undruggable(2014)264 cited
- → The use of lipid-based nanocarriers for targeted pain therapies(2013)258 cited